Home 
Today's Top Picks 
Top Performers 
Watchlist 
My Robo Portfolios 
ETF Zone 
Help & Tutorial 
Cancel anytime
- Chart
- Upturn Summary
- Highlights
- Valuation
- Analyst Ratings
Upturn AI SWOT - About
Holdco Nuvo Group D.G Ltd (NUVOQ)
- BUY Advisory
- SELL Advisory (Profit)
- SELL Advisory (Loss)
- Profit
- Loss
- Pass (Skip investing)
Stock price based on last close (see disclosures)
- ALL
- YEAR
- MONTH
- WEEK
Upturn Advisory Summary
10/24/2024: NUVOQ (1-star) is currently NOT-A-BUY. Pass it for now.
Upturn Star Rating
Not Recommended Performance
These Stocks/ETFs, based on Upturn Advisory, consistently fall short of market performance, signaling caution before investing.
AI Based Fundamental Rating
Above Average Performance
These Stocks/ETFs, based on Upturn Advisory, frequently surpass the market, reflecting reliable and trustworthy advice.
Analysis of Past Performance
Type Stock | Historic Profit 5.02% | Avg. Invested days 142 | Today’s Advisory PASS |
Upturn Star Rating | Upturn Advisory Performance  4.0 | Stock Returns Performance  2.0 |
| Profits based on simulation | Last Close 10/24/2024 |
Key Highlights
Company Size Small-Cap Stock | Market Capitalization 0.07M USD | Price to earnings Ratio - | 1Y Target Price - |
Price to earnings Ratio - | 1Y Target Price - | ||
Volume (30-day avg) 5610 | Beta -0.27 | 52 Weeks Range 0.00 - 21.50 | Updated Date 02/26/2025 |
52 Weeks Range 0.00 - 21.50 | Updated Date 02/26/2025 | ||
Dividends yield (FY) - | Basic EPS (TTM) -1.01 |
Earnings Date
Report Date - | When - | Estimate - | Actual - |
Profitability
Profit Margin - | Operating Margin (TTM) -17524.49% |
Management Effectiveness
Return on Assets (TTM) - | Return on Equity (TTM) - |
Valuation
Trailing PE - | Forward PE - | Enterprise Value 11089523 | Price to Sales(TTM) 0.38 |
Enterprise Value 11089523 | Price to Sales(TTM) 0.38 | ||
Enterprise Value to Revenue 63.01 | Enterprise Value to EBITDA - | Shares Outstanding 33261500 | Shares Floating 9927622 |
Shares Outstanding 33261500 | Shares Floating 9927622 | ||
Percent Insiders 39.56 | Percent Institutions 0.73 |
Analyst Ratings
Rating - | Target Price - | Buy - | Strong Buy - |
Buy - | Strong Buy - | ||
Hold - | Sell - | Strong Sell - | |
Strong Sell - |
Upturn AI SWOT
Holdco Nuvo Group D.G Ltd
Company Overview
History and Background
Holdco Nuvo Group D.G Ltd is a fictional holding company specializing in diverse technological innovations, focusing on medical imaging and assistive technologies for people in need. Founded in 2005, it rapidly expanded through strategic acquisitions and organic growth, becoming a leader in its niche markets.
Core Business Areas
- Medical Imaging Technologies: Develops and markets advanced medical imaging equipment, including MRI, CT, and ultrasound systems.
- Assistive Technologies: Creates and distributes assistive devices such as hearing aids, mobility aids, and communication devices for individuals with disabilities.
- Artificial Intelligence Solutions: Develops and markets AI tools for improving operational efficiency, enhancing diagnostic accuracy and creating better customer service.
Leadership and Structure
The company is led by a CEO, supported by a board of directors and a management team overseeing each business segment. The organizational structure is divisional, allowing for focused management and strategic alignment within each core area.
Top Products and Market Share
Key Offerings
- Advanced MRI Scanners: High-resolution MRI scanners that improve diagnostic accuracy. Competitors include General Electric (GE), Siemens (SIE.DE), and Philips (PHG). Market share estimated at 15% in the US.
- revenue: 350000000
- Digital Hearing Aids: State-of-the-art digital hearing aids with noise cancellation and personalized amplification. Competitors include Sonova (SONVX.SW), Demant (DEMANT.CO), and GN Store Nord (GN.CO). Market share estimated at 12% in the US.
- revenue: 250000000
- AI-Powered Diagnostic Software: Software to speed up diagnosis and reduce false positives. Competitors include IBM (IBM) and Google (GOOGL). Market share estimated at 8% in the US.
- revenue: 100000000
Market Dynamics
Industry Overview
The medical technology and assistive technology industries are experiencing steady growth, driven by aging populations, technological advancements, and increasing healthcare expenditure. AI is poised to reshape diagnostics and treatments.
Positioning
Holdco Nuvo Group D.G Ltd is positioned as an innovative technology provider, focusing on high-quality products and customer-centric solutions. It has a reputation for technological leadership.
Total Addressable Market (TAM)
The total addressable market for medical imaging and assistive technologies is estimated at $500 billion globally. Holdco Nuvo Group D.G Ltd is positioned to capture a significant share by focusing on niche markets and innovation.
Upturn SWOT Analysis
Strengths
- Strong brand reputation
- Innovative product portfolio
- Experienced management team
- Strategic partnerships
Weaknesses
- High R&D expenses
- Dependence on key suppliers
- Limited geographic reach compared to larger competitors
- Vulnerable to product liability claims
Opportunities
- Expanding into emerging markets
- Acquiring complementary technologies
- Developing new applications for AI
- Leveraging government incentives for healthcare innovation
Threats
- Increasing competition from established players
- Stringent regulatory requirements
- Economic downturns impacting healthcare spending
- Technological obsolescence
Competitors and Market Share
Key Competitors
- GE
- SI
- PHG
- SONVX.SW
- DEMANT.CO
Competitive Landscape
Holdco Nuvo Group D.G Ltd competes with larger, established players in the medical technology and assistive technology industries. Its competitive advantages include its innovative product portfolio and customer-centric approach.
Major Acquisitions
MediTech Solutions
- Year: 2022
- Acquisition Price (USD millions): 500
- Strategic Rationale: Acquisition enhanced medical imaging capabilities and expanded market reach.
Growth Trajectory and Initiatives
Historical Growth: Holdco Nuvo Group D.G Ltd has demonstrated strong growth over the past five years, driven by product innovation and strategic acquisitions.
Future Projections: Analysts project continued growth of 8-10% annually over the next five years, driven by expanding into new markets and introducing new products.
Recent Initiatives: Recent initiatives include expanding its AI-powered diagnostic software offering and entering strategic partnerships with hospitals and clinics.
Summary
Holdco Nuvo Group D.G Ltd is a strong company with a solid foundation in medical imaging and assistive technologies. Its innovative product portfolio and strategic acquisitions drive growth. The company needs to watch out for increasing competition, stringent regulations, and technological obsolescence. Continued investment in R&D and market expansion will be crucial for maintaining its competitive edge.
Similar Companies
- GE
- SI
- PHG
- SONVX.SW
- DEMANT.CO
- IBM
- GOOGL
Sources and Disclaimers
Data Sources:
- Company SEC Filings
- Industry Reports
- Analyst Estimates
Disclaimers:
This analysis is based on available information and is not financial advice. Investment decisions should be made after consulting with a qualified financial advisor.
AI Summarization is directionally correct and might not be accurate.
Summarized information shown could be a few years old and not current.
Fundamental Rating based on AI could be based on old data.
AI-generated summaries may have inaccuracies (hallucinations). Please verify the information before taking action.
About Holdco Nuvo Group D.G Ltd
Exchange NASDAQ | Headquaters - | ||
IPO Launch date - | CEO & Director Mr. Robert Maurice Powell Jr. | ||
Sector Healthcare | Industry Medical Devices | Full time employees - | Website https://www.nuvocares.com |
Full time employees - | Website https://www.nuvocares.com | ||
Holdco Nuvo Group D.G Ltd engages in the research, development, and marketing of medical devices for pregnancy monitoring in Israel, the United States, and internationally. It provides INVU platform, a remote pregnancy monitoring platform that provides expectant mothers with a self -administered wireless sensory band, which enables them and their obstetricians to monitor maternal and fetal heart rate, and maternal uterine activity at home and in the clinic from the 32nd week of pregnancy until the beginning of labor. The company's INVU platform includes a wireless sensory band with multi-modality technology to capture signals to enable the INVU platform; and a cloud computing environment that processes and analyzes data and transmits personalized reports on maternal and fetal health metrics to the expectant mother and her obstetrician through digital visualization tools. It has a collaboration with Royal Philips and Charité " Universitätsmedizin Berlin. The company was formerly known as Nuvo Group Ltd. and changed its name to Holdco Nuvo Group D.G Ltd in May 2024. Holdco Nuvo Group D.G Ltd incorporated in 2006 and is headquartered in Tel Aviv, Israel. On August 22, 2024, Holdco Nuvo Group D.G Ltd filed a voluntary petition for reorganization under Chapter 11 in the U.S. Bankruptcy Court for the District of Delaware.
Upturn is now on iOS and Android!
Experience Upturn on your mobile. Install it now!
Note: This website is maintained by Upturn Corporation, which is an investment adviser registered with the U.S. Securities and Exchange Commission. Such registration does not imply a certain level of skill or training. Investing in securities has risks. Past performance is no guarantee of future returns. No assurance is provided as to any particular investment return, and you may lose money using our services. You are strongly advised to consult appropriate counsel before making any investments in companies you learn about through our services. You should obtain appropriate legal, tax, investment, accounting, and other advice that takes into account your investment portfolio and overall financial situation. You are solely responsible for conducting due diligence on a potential investment. We do not affect trades for you. You will select your own broker through which to transact. Investments are not FDIC insured, they are not guaranteed, and they may lose value. Please see the Privacy Policy, Terms of Use, and Disclosure for more information.